The CE Mark is the mandatory regulatory designation required to commercially market and sell the OncoSil™ medical device in the European Union. OncoSil now awaits the final outcome of the review as the Notified Body continues its assessment over the coming weeks.
News: OncoSil Medical completes Fast Track Face-to-Face for CE Mark
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.4¢ | $39.49K | 2.821M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2673846 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 2297855 | 6 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| OSL (ASX) Chart |